The long term objective of this research is to further our knowledge of the molecular mechanisms involved in the transmission of hormone and growth factor signals within cells. Particular attention will be paid to steps of the transmission pathways that involve protein phosphorylation- dephosphorylation reactions catalyzed by protein kinases and protein phosphatases, respectively. In one such pathway, the MAP kinase (MK) cascade, a series of protein kinases are involved. Listed sequentially, they include (1) a MAP kinase kinase (MAPKKK). At least three different kinases that fit in this category are known, the most studied one being the enzyme encoded by Raf-1; (2) MAP kinase (MAPKK), which is also referred to as MEK; (3) MAPK itself (MAPK); and (4) several MAPK- activated kinases, the most studied of which is p90rsk, or RSK. The completion of this cascade and the establishment of its linkage to growth factor receptors was achieved only recently; numerous laboratories, including the applicant's, participated in bringing this phase of research to fruition. Now that the components of the cascade have been defined, attention is shifting to questions related to the functions of this pathway, its regulation, and its interactions with other signaling systems.
The specific aims of the present project are concerned with the characterization and mechanism of activation of several different forms of MAPKK, """"""""cross-talk"""""""" between the MAPK cascade and other signaling systems, and the physiological role of the cascade in the regulation of growth, differentiation, and metabolism. Additionally, the functional and regulatory properties of a multifunctional protein serine/threonine kinase, casein kinase II (CKII), will be characterized. In pursuit of the goals, extensive use will be made of new methods for studying protein-protein interactions, including specific experiments directed toward interactions of MAP cascade components with the cytoskeleton. Functional studies concerned with the role of the cascade in cell growth, differentiation, and the cell cycle will make use of the overexpression of hyperactive and dominant negative mutant forms of several protein kinases of the cascade. Although the project emphasizes studies on the regulation and role of MAPKK, it will also include work on proposed roles of the more distal enzyme RSK. In particular, the role of RSK in the regulation of GSK-3 and one form of protein phosphatase-1, enzymes known to be important in the regulation of glycogen synthase, will be studied. New approaches will be used to solve the difficult problem as to how the activity of CKII is controlled within the cell and how this enzyme works in conjunction with GSK-3. These experiments should shed further light on basic aspects of growth factor functions and the regulation of cell growth and differentiation. This research is relevant to neoplastic disease and also to metabolic hormonal disorders such as diabetes mellitus.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042528-10
Application #
2900226
Study Section
Biochemistry Study Section (BIO)
Program Officer
Sato, Sheryl M
Project Start
1990-06-01
Project End
2001-03-31
Budget Start
1999-04-01
Budget End
2001-03-31
Support Year
10
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Washington
Department
Pharmacology
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Zhao, A Z; Shinohara, M M; Huang, D et al. (2000) Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J Biol Chem 275:11348-54
Li, D; Dobrowolska, G; Aicher, L D et al. (1999) Expression of the casein kinase 2 subunits in Chinese hamster ovary and 3T3 L1 cells provides information on the role of the enzyme in cell proliferation and the cell cycle. J Biol Chem 274:32988-96
Wright, J H; Munar, E; Jameson, D R et al. (1999) Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc Natl Acad Sci U S A 96:11335-40
Eldar-Finkelman, H; Schreyer, S A; Shinohara, M M et al. (1999) Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes 48:1662-6
Dobrowolska, G; Lozeman, F J; Li, D et al. (1999) CK2, a protein kinase of the next millennium. Mol Cell Biochem 191:3-12
Bornfeldt, K E; Krebs, E G (1999) Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell Signal 11:465-77
Spring, D J; Krebs, E G (1999) Deletion of 11 amino acids in p90(rsk-mo-1) abolishes kinase activity. Mol Cell Biol 19:317-20
Torres, M A; Eldar-Finkelman, H; Krebs, E G et al. (1999) Regulation of ribosomal S6 protein kinase-p90(rsk), glycogen synthase kinase 3, and beta-catenin in early Xenopus development. Mol Cell Biol 19:1427-37
Wright, J H; Drueckes, P; Bartoe, J et al. (1997) A role for the SHP-2 tyrosine phosphatase in nerve growth-induced PC12 cell differentiation. Mol Biol Cell 8:1575-85
Eldar-Finkelman, H; Krebs, E G (1997) Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc Natl Acad Sci U S A 94:9660-4

Showing the most recent 10 out of 45 publications